Brief: Aquestive Therapeutics Enters License And Supply Agreement With Pharmanovia For Libervant™ (Diazepam) Buccal Film For European And MENA Markets
28/09/2022 13:04
Sept 28 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS ENTERS LICENSE AND SUPPLY AGREEMENT
WITH
PHARMANOVIA FOR LIBERVANT™ (DIAZEPAM) BUCCAL FILM FOR EUROPEAN
AND MENA MARKETS
* AQUESTIVE THERAPEUTICS INC - PURSUANT TO AGREEMENT,
AQUESTIVE
THERAPEUTICS WILL SERVE AS EXCLUSIVE SOLE MANUFACTURER AND
SUPPLIER FOR PRODUCT
* AQUESTIVE THERAPEUTICS INC - PHARMANOVIA WILL BE
RESPONSIBLE FOR
ALL REGULATORY AND COMMERCIALIZATION ACTIVITIES
* AQUESTIVE THERAPEUTICS INC - AQUESTIVE WILL RECEIVE AN
UNDISCLOSED UPFRONT PAYMENT
Source text for Eikon: ID:nGNXb5w4xD
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million